The Net Margin of Enorama Pharma AB (ERMA.ST) is -277.82%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date | Value |
|---|---|
| 2024-12-31 | -277.82% |
| 2023-12-31 | -3285.20% |
| 2022-12-31 | -613.85% |
| 2021-12-31 | -251.38% |
| 2020-12-31 | -1093.01% |
| 2019-12-31 | -312.70% |
| 2018-12-31 | -310.87% |
| 2017-12-31 | -556.67% |